ClinicalTrials.Veeva

Menu

Patient Utilization of Opioid Destruction Bags in the Post-op Period

University of Nebraska logo

University of Nebraska

Status

Active, not recruiting

Conditions

Total Hip Arthroplasty
Patient Empowerment
Total Knee Arthoplasty
Opioid Use
Opioid Use, Unspecified

Treatments

Behavioral: Opioid destruction education

Study type

Interventional

Funder types

Other

Identifiers

NCT05875857
0277-22-EP

Details and patient eligibility

About

This is a study on how patients use and store opioid pain medications at home after surgery and what happens to left over pills when patients are done taking them. Participants will be taught the proper storage and destruction of opioid pain medications, then contacted in 6-8 weeks about pain medication used, stored disposed of.

Full description

This is a randomized single-center prospective survey study to describe the utilization of opioid destruction bags in the post-operative period. Participants who underwent surgery for Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) will be eligible for inclusion if discharging to home with an opioid prescription. Eligible participants will be randomized between two groups: 1) Control group will receive current standard of care 2) Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Participants will be phoned/emailed six to eight weeks post-surgery to complete a survey. Attempts will be made on three separate days to reach the participant via phone. If email is preferred, three reminders will be sent to complete the survey. If participant is unreachable, they will be considered lost to follow up. Survey questions will be comprised of various question styles, including: yes/no, multiple choice, and free text answers.

Enrollment

163 patients

Sex

All

Ages

19 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

19 years of age or older Discharging to home and prescribed opioids at discharge post total knee arthroplasty or total hip arthroplasty

Exclusion criteria

Under 19 years of age Opioid medication use prior to surgery Not prescribed an opioid to take after discharge

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

163 participants in 2 patient groups

Control
No Intervention group
Description:
Control group will receive current standard of care education and surveys at 6-8 weeks post discharge.
Intervention
Experimental group
Description:
Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Surveys will be sent to group at 6-8 weeks post discharge.
Treatment:
Behavioral: Opioid destruction education

Trial contacts and locations

1

Loading...

Central trial contact

Stacie J Ethington, MSN RN; Kristin R Daniel, PharmD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems